rs368313959
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_016023.5(OTUD6B):c.343C>T(p.Arg115Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000543 in 1,585,064 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_016023.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTUD6B | NM_016023.5 | c.343C>T | p.Arg115Ter | stop_gained | 4/7 | ENST00000404789.8 | NP_057107.4 | |
OTUD6B | NM_001416022.1 | c.262C>T | p.Arg88Ter | stop_gained | 3/6 | NP_001402951.1 | ||
OTUD6B | NM_001286745.3 | c.40C>T | p.Arg14Ter | stop_gained | 5/8 | NP_001273674.1 | ||
OTUD6B | XM_011517129.3 | c.40C>T | p.Arg14Ter | stop_gained | 4/7 | XP_011515431.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTUD6B | ENST00000404789.8 | c.343C>T | p.Arg115Ter | stop_gained | 4/7 | 1 | NM_016023.5 | ENSP00000384190 |
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 152016Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000158 AC: 33AN: 209016Hom.: 0 AF XY: 0.000143 AC XY: 16AN XY: 111606
GnomAD4 exome AF: 0.0000502 AC: 72AN: 1433048Hom.: 0 Cov.: 33 AF XY: 0.0000465 AC XY: 33AN XY: 709984
GnomAD4 genome AF: 0.0000921 AC: 14AN: 152016Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74266
ClinVar
Submissions by phenotype
Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 05, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | May 03, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 24, 2020 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 21, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 28343629, 32924626) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 15, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 375701). This premature translational stop signal has been observed in individual(s) with an intellectual disability syndrome that includes seizures and facial dysmorphism (PMID: 28343629). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs368313959, gnomAD 0.08%). This sequence change creates a premature translational stop signal (p.Arg145*) in the OTUD6B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OTUD6B are known to be pathogenic (PMID: 28343629). - |
Epilepsy;C0432072:Dysmorphic features;C3714756:Intellectual disability Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 09, 2017 | This nonsense variant has been observed in our laboratory homozygous in 4 probands: 20-year-old female with hemihypertrophy, intellectual disability, epilepsy, contractures, brachydactyly; 14-year-old male with IUGR, intellectual disability, SNHL, dystonia, epilepsy, dysmorphisms, short stature, microcephaly, contractures, scoliosis, hypogammaglobulinemia, brain abnormalities; 18-year-old female with hearing loss, epilepsy, dysmorphic features, microcephaly, failure to thrive, scoliosis, contractures, quadriplegia, hypothyroidism, intellectual disability, recurrent infections; 1-year-old female with developmental delays, hypotonia, dysmorphisms, microcephaly, congenital heart disease, unilateral retinoblastoma, reduced cerebral white matter, mild ventriculomegaly. One of these had a deceased sibling with similar features (not tested). An additional family was identified through research with 4 similarly affected sibs (2 deceased): 3 found to be homozygous, 1 not tested. Heterozygotes are expected to be asymptomatic carriers. - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2022 | The c.433C>T (p.R145*) alteration, located in exon 4 (coding exon 4) of the OTUD6B gene, consists of a C to T substitution at nucleotide position 433. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 145. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on data from gnomAD, the T allele has an overall frequency of 0.01% (36/240398) total alleles studied. The highest observed frequency was 0.09% (29/30828) of Latino alleles. This variant has been reported in the homozygous state in multiple unrelated individuals with syndromic intellectual disability (Santiago-Sim, 2017; Sánchez-Soler, 2020; Romero-Ibarguengoitia, 2020). Based on the available evidence, this alteration is classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at